Care pathways for reduced fetal movements: A cost-consequence analysis

被引:0
|
作者
Mcknoulty, Matthew J. [1 ]
Martin, Elizabeth K. [2 ]
机构
[1] Univ Queensland, Metro North Hlth, Queensland Hlth, Brisbane, Qld, Australia
[2] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia
关键词
costs and costs analysis; health services research; midwifery; obstetrics; stillbirth;
D O I
10.1111/ajo.13883
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective This study aimed to evaluate the costs and consequences of a new midwife-navigator-facilitated care pathway for reduced fetal movements. Materials and Methods This study was conducted at a tertiary obstetric centre in Queensland, Australia and modelling occurred for this and smaller services. Two months of data from pre (n = 112 in 2019) and post (n = 141 in 2020) implementation of the care pathway were analysed with T-tests and logistic regression models to evaluate maternal and neonatal outcomes. A Markov model was built to estimate the costs and consequences of the intervention. Sensitivity analysis was conducted to test various scenarios including modelling for smaller centres. Results There were no statistically significant differences in clinical outcome between the intervention and usual care groups. Intervention patients spent one hour and eight minutes less time in hospital (P < 0.001). This resulted in a saving to the centre of AU$135 per patient (AU$159 083 annually). One-way sensitivity analysis suggested that cost savings would be found in all scenarios except for smaller units providing services for less than 1900 births per annum. Conclusion(s) To our knowledge, no other care pathway involving acute obstetric care has been economically evaluated to date. Our model based on real-world presentations for reduced fetal movements confirms that midwife-navigators may be an economically beneficial implementation strategy for dealing with common obstetric conditions.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] USE OF COST-CONSEQUENCE MODELS IN MANAGED CARE
    BLISSENBACH, HF
    [J]. PHARMACOTHERAPY, 1995, 15 (05): : S59 - S61
  • [2] Cost-consequence analysis for the handmaster in the Netherlands
    Nuijten, MJ
    Engelfriet, P
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A151 - A151
  • [3] A cost-consequence analysis of a menu intervention in early childhood education and care
    Kurkela, Olli
    Virtanen, S. M.
    Erkkola, M.
    Saarinen, M.
    Niinisto, S.
    Raulio, S.
    Ahokas, I.
    Meinila, J.
    Forma, L.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2023, 33
  • [4] Cost-Consequence Analysis of Advanced Imaging in Acute Ischemic Stroke Care
    Boltyenkov, Artem T.
    Martinez, Gabriela
    Pandya, Ankur
    Katz, Jeffrey M.
    Wang, Jason J.
    Naidich, Jason J.
    Rula, Elizabeth
    Sanelli, Pina C.
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [5] A COST-CONSEQUENCE ANALYSIS OF HUMAN PAPILLOMAVIRUS VACCINATION IN ROMANIA
    Preda, A. L.
    Moise, M.
    Van Kriekinge, G.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A631 - A631
  • [6] Psychological safety in the perioperative environment: a cost-consequence analysis
    Cladis, Franklyn P.
    Hudson, Mark
    Goh, Joel
    [J]. BMJ LEADER, 2024,
  • [7] A BIBLIOMETRICS ANALYSIS OF COST-CONSEQUENCE ANALYSIS USED IN ECONOMICAL EVALUATIONS
    Xin, G.
    Zhang, G.
    Malone, D.
    Tang, W.
    [J]. VALUE IN HEALTH, 2019, 22 : S323 - S323
  • [8] COST-CONSEQUENCE ANALYSIS OF ROSUVASTATIN VERSUS ATORVASTATIN IN THE SPANISH SETTING
    Mata, P.
    Cortes, X.
    Marti, I
    Saborit-Canals, G.
    Pomares, E.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S118 - S118
  • [9] Cost-Consequence Analysis of Mobile Stroke Units vs. Standard Prehospital Care and Transport
    Reimer, Andrew P.
    Zafar, Atif
    Hustey, Fredric M.
    Kralovic, Damon
    Russman, Andrew N.
    Uchino, Ken
    Hussain, Muhammad Shazam
    Udeh, Belinda L.
    [J]. FRONTIERS IN NEUROLOGY, 2020, 10
  • [10] Overcoming the limitations of the cost-utility framework using a cost-consequence analysis
    Heggie, Robert
    Jaiswal, Nishant
    Mccartney, Elaine
    Moss, Jon
    Menne, Tobias
    Jones, Brian
    Boyd, Kathleen
    Soulis, Eileen
    Hawkins, Neil
    Wu, Olivia
    [J]. MEDICAL DECISION MAKING, 2024, 44 (02) : NP167 - NP168